🇺🇸
United States · US · US:62332-678_59e116c8-6ba0-4459-b71b-75ad9492ff14
Docetaxel
In shortageOrange BookUNIISPLATC L01CD02
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerAlembic Pharmaceuticals Inc.
CountryUS (United States)
ATC codeL01CD02
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 3
- ndc1162332678021 VIAL, SINGLE-DOSE in 1 CARTON (62332-678-02) / 2 mL in 1 VIAL, SINGLE-DOSE
- ndc1162332678081 VIAL, MULTI-DOSE in 1 CARTON (62332-678-08) / 8 mL in 1 VIAL, MULTI-DOSE
- ndc1162332678161 VIAL, MULTI-DOSE in 1 CARTON (62332-678-16) / 16 mL in 1 VIAL, MULTI-DOSE
Annotations
UNII (FDA Substance ID)
699121PHCA
DOCETAXEL ANHYDROUS
RxCUI 1299922
Orange Book
A215744
APAPAP
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Docetaxel Injection
Raw payload (JSON)
{
"unii": {
"unii": "699121PHCA",
"rxcui": "1299922",
"inchikey": "ZDZOTLJHXYCWBA-VCVYQWHSSA-N",
"display_name": "DOCETAXEL ANHYDROUS",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAVENOUS",
"spl_meta": {
"81686d37-a13f-46e2-b439-a84eb1433634": {
"match": "brand_token",
"title": "DOCETAXEL INJECTION [HERITAGE PHARMACEUTICALS INC. D/B/A AVET PHARMACEUTICALS INC.]",
"spl_version": "2",
"published_date": "2026-05-13"
}
},
"productid": "62332-678_59e116c8-6ba0-4459-b71b-75ad9492ff14",
"productndc": "62332-678",
"dosage_form": "INJECTION",
"orange_book": {
"appl_no": "215744",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AP",
"strength": "20MG/2ML (10MG/ML)",
"product_no": "001",
"approval_date": "Feb 28, 2023"
},
{
"rs": false,
"rld": false,
"te_code": "AP",
"strength": "80MG/8ML (10MG/ML)",
"product_no": "002",
"approval_date": "Feb 28, 2023"
},
{
"rs": false,
"rld": false,
"te_code": "AP",
"strength": "160MG/16ML (10MG/ML)",
"product_no": "003",
"approval_date": "Feb 28, 2023"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "DOCETAXEL ANHYDROUS",
"shortage_reason": "Docetaxel Injection",
"shortage_status": "current",
"proprietary_name": "Docetaxel",
"active_ingred_unit": "mg/mL",
"application_number": "ANDA215744",
"marketing_category": "ANDA",
"nonproprietary_name": "Docetaxel",
"start_marketing_date": "20230228",
"active_numerator_strength": "10"
}Related drugs
Other records sharing ATC code L01CD02.
- BEBaglycacon 10 mg/mlSandoz
- BEBaglycacon 10 mg/mlSandoz
- BEBaglycacon 10 mg/mlSandoz
- 🇺🇸BEIZRAYZydus Pharmaceuticals USA Inc.
- 🇺🇸BEIZRAYZydus Pharmaceuticals USA Inc.
- 🇺🇸BEIZRAYZhuhai Beihai Biotech Co., Ltd.
- 🇺🇸BEIZRAYZhuhai Beihai Biotech Co., Ltd.
- NLDemotaxel Mono 20 mg/ml, concentraat voor oplossing voor infusieDemo S.A. Pharmaceutical Industry
Access this data programmatically
Query Docetaxel and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.